Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4404 |  MCRB Seres Therapeutics, Inc. - Common Stock | 2.63 USD | -3.31% | -11.74% | -49.52% | -68.04% | 26.15 M USD | ||
| 4406 |  ABVC ABVC BioPharma, Inc. - Common Stock | 0.98 USD | -2.00% | -4.85% | +6.52% | -69.94% | 26.12 M USD | ||
| 4408 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.26 USD | -7.14% | -10.34% | -44.68% | -73.20% | 25.50 M USD | ||
| 4410 |  EVAX Evaxion A/S - American Depositary Share | 3.05 USD | -2.87% | -5.57% | -7.29% | -8.13% | 25.44 M USD | ||
| 4415 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 0.61 USD | -4.69% | -26.51% | 0.00% | -66.67% | 25.08 M USD | ||
| 4432 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.42 USD | -1.63% | +8.52% | +2.54% | +106.84% | 24.15 M USD | ||
| 4433 |  KYNB Kyntra Bio, Inc. - Common Stock | 5.96 USD | -1.32% | -9.70% | -29.22% | -37.33% | 24.13 M USD | ||
| 4474 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.07 USD | 0.00% | -8.55% | -15.08% | -13.71% | 20.61 M USD | ||
| 4503 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.56 USD | -1.75% | -6.67% | -18.84% | -77.60% | 18.63 M USD | ||
| 4504 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.42 USD | 0.00% | -8.70% | -32.26% | -66.40% | 18.27 M USD | ||
| 4509 |  NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.35 USD | -2.05% | -6.69% | -11.61% | -82.41% | 18.13 M USD | ||
| 4528 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 0.71 USD | -6.58% | -13.41% | -23.66% | -78.81% | 16.64 M USD | ||
| 4532 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 8.49 USD | -1.62% | -5.77% | -20.13% | +793.68% | 16.53 M USD | ||
| 4538 |  ACTU Actuate Therapeutics, Inc. - Common stock | 0.68 USD | -5.56% | -26.88% | -45.60% | -83.33% | 16.33 M USD | ||
| 4541 |  BCDA BioCardia, Inc. - Common Stock | 1.06 USD | -2.75% | +1.92% | -2.75% | -8.62% | 16.05 M USD | ||
| 4543 |  PTN Palatin Technologies, Inc. Common Stock | 9.01 USD | -5.36% | +3.56% | -26.57% | +24.28% | 16.05 M USD | ||
| 4544 |  DYAI Dyadic International, Inc. - Common Stock | 0.44 USD | -4.35% | -4.35% | -13.73% | -61.06% | 16.03 M USD | ||
| 4546 |  LPCN Lipocine Inc. - Common Stock | 1.93 USD | -12.27% | -8.53% | -17.87% | -33.45% | 15.91 M USD | ||
| 4548 |  MRKR Marker Therapeutics, Inc. - Common Stock | 0.95 USD | -8.65% | -10.38% | -21.49% | -10.38% | 15.84 M USD | ||
| 4554 |  ALLR Allarity Therapeutics, Inc. - Common stock | 0.98 USD | 0.00% | -7.55% | -24.03% | -44.32% | 15.59 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |